Home > Boards > US Listed > Medical - Healthcare > Zomedica (ZOM)

Price is coming back. I see a push coming

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
tantalos60 Member Profile
 
Followed By 23
Posts 1,229
Boards Moderated 0
Alias Born 05/21/10
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2020 4:02:25 PM
Zomedica Sets March 30, 2021 as Expected Commercialization Date for TRUFORMA™ GlobeNewswire Inc. - 11/13/2020 6:00:00 AM
Zomedica Announces Third Quarter 2020 Financial Results GlobeNewswire Inc. - 11/12/2020 6:29:46 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2020 6:27:25 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2020 6:17:29 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/27/2020 6:04:17 AM
Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Special Virtual... GlobeNewswire Inc. - 10/26/2020 9:25:10 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 10/26/2020 9:23:15 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/26/2020 9:21:56 AM
Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) Edgar (US Regulatory) - 10/22/2020 4:02:37 PM
Securities Registration: Business Combination (s-4) Edgar (US Regulatory) - 10/9/2020 1:57:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/6/2020 4:38:24 PM
Zomedica Announces Name Change GlobeNewswire Inc. - 10/2/2020 5:05:10 PM
Zomedica Announces Shareholder Meeting Voting Results GlobeNewswire Inc. - 9/25/2020 11:00:10 AM
Zomedica Announces Letter to Shareholders in Connection With Annual and Special Virtual-Only Meeting   GlobeNewswire Inc. - 9/14/2020 5:44:56 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 9/14/2020 5:20:52 PM
Zomedica Announces Presentation at Upcoming H.C. Wainwright Virtual Global Investment Conference GlobeNewswire Inc. - 9/10/2020 6:55:10 AM
Zomedica to Develop Gastrointestinal Testing Panel for TRUFORMA™ GlobeNewswire Inc. - 9/8/2020 6:55:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/27/2020 7:40:45 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 8/27/2020 7:35:48 AM
Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Annual and Specia... GlobeNewswire Inc. - 8/27/2020 6:55:10 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 8/20/2020 4:01:59 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/14/2020 4:28:47 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 8/14/2020 4:08:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/10/2020 4:25:29 PM
tantalos60   Wednesday, 11/18/20 12:44:24 PM
Re: tantalos60 post# 1101
Post # of 1140 
Price is coming back.
I see a push coming once profit is happy.
My opinion now leans toward .30 cents in the short term.
We have traded 2x the outstanding shares in the last two weeks. That is a lot of shares. Churning will run us up. Higher lows is how it usually works.
Seen it before, many times.
It doesn't look like dilution.
They have 52 million in the bank.
They don't need to tap into their stock
base.
What do we now know?
They have a product protected by 70 patents awarded or applied for.
The basis of their applied tech is based on
using already proven technology.
They have given a release date for sales.
They are already widening their application with additional testing protocols.
The additional testing protocols should be in place before they release their product.
They are excited by it and stand by it.


"Rise early, work hard, strike oil" J. Paul Getty
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences